English  |  正體中文  |  简体中文  |  Total items :2853522  
Visitors :  45201315    Online Users :  737
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"楊志新"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 91-100 of 209  (21 Page(s) Totally)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
View [10|25|50] records per page

Institution Date Title Author
國立臺灣大學 2013 Diarrhea associated with afatinib: an oral ErbB family blocker Yang, James Chih-Hsin; Reguart, Noemi; Barinoff, Jana; Koehler, Jens; Uttenreuther-Fischer, Martina; Stammberger, Uz; O'Brien, Dennis; Wolf, Juergen; Cohen, Ezra E. W.; 楊志新
國立臺灣大學 2013 Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study Wu, Yi-Long; Fukuoka, Masahiro; Mok, Tony S. K.; Saijo, Nagahiro; Thongprasert, Sumitra; Yang, James C. H.; Chu, Da-Tong; Yang, Jin-Ji; Rukazenkov, Yuri; 楊志新
國立臺灣大學 2013 Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations Sequist, Lecia V.; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Mok, Tony; Geater, Sarayut Lucien; Orlov, Sergey; Tsai, Chun-Ming; Boyer, Michael; Su, Wu-Chou; Bennouna, Jaafar; Kato, Terufumi; Gorbunova, Vera; Lee, Ki Hyeong; Shah, Riyaz; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Schuler, Martin; 楊志新
國立臺灣大學 2012 EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR Wu, Shang-Gin; Kuo, Yao-Wen; Chang, Yih-Leong; Shih, Jin-Yuan; Chen, Ya-Hui; Tsai, Meng-Feng; Yu, Chong-Jen; Yang, Chih-Hsin; Yang, Pan-Chyr; 楊志新; 張逸良; 楊泮池; 余忠仁; 郭耀文; 吳尚俊; 施金元; 陳盈憲
國立臺灣大學 2012 Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial Yang, James Chih-Hsin; Shih, Jin-Yuan; Su, Wu-Chou; Hsia, Te-Chun; Tsai, Chun-Ming; Ou, Sai-Hong Ignatius; Yu, Chung-Jen; Chang, Gee-Chen; Ho, Ching-Liang; Sequist, Lecia V.; Dudek, Arkadiusz Z.; Shahidi, Mehdi; Cong, Xiuyu Julie; Lorence, Robert M.; Yang, Pan-Chyr; Miller, Vincent A.; 楊志新; 楊泮池; 余忠仁; 施金元
國立臺灣大學 2012 Effusion Immunocytochemistry as an Alternative Approach for the Selection of First-Line Targeted Therapy in Advanced Lung Adenocarcinoma Tsai, Tzu-Hsiu; Wu, Shang-Gin; Chang, Yih-Leong; Wu, Chen-Tu; Tsai, Meng-Feng; Wei, Pin-Fei; Yang, Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr; Shih, Jin-Yuan; 吳振都; 楊志新; 張逸良; 楊泮池; 余忠仁; 衛品妃; 吳尚俊; 蔡子修; 施金元
國立臺灣大學 2012 Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non-Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum Liao, Wei-Yu; Shih, Jin-Yuan; Chang, Gee-Chen; Cheng, Yu-Kai; Yang, James Chih-Hsin; Chen, Yuh-Min; Yu, Chong-Jen; 楊志新; 廖唯昱; 余忠仁; 施金元
國立臺灣大學 2012 Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin Chang, Yeun-Chung; Yu, Chong-Jen; Chen, Chung-Ming; Hu, Fu-Chang; Hsu, Hao-Hsiang; Tseng, Wen-Yih I.; Shih, Tiffany Ting-Fang; Yang, Pan-Chyr; Yang, James Chih-Hsin; 曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強
國立臺灣大學 2012 Factors Impacting Prognosis Prediction in BCLC Stage C and Child-Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy Lin, Zhong-Zhe; Hsu, Chiun; Hu, Fu-Chang; Shao, Yu-Yun; Chang, Dwan-Ying; Yang, Chih-Hsin; Hong, Ruey-Long; Hsu, Chih-Hung; Cheng, Ann-Lii; 楊志新; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 洪瑞隆; 許駿; 胡賦強; 張端瑩
國立臺灣大學 2012 Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors Hsu, Chia-Lin; Chen, Kuan-Yu; Shih, Jin-Yuan; Ho, Chao-Chi; Yang, Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr; 楊志新; 楊泮池; 許嘉林; 陳冠宇; 余忠仁; 何肇基; 施金元

Showing items 91-100 of 209  (21 Page(s) Totally)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
View [10|25|50] records per page